01 1Bamboo US Bidco LCC
02 3Excella GmbH & Co. KG
03 1Formosa Laboratories, Inc.
04 1Hetero Labs Limited
05 1Hubei Haosun Pharmaceutical Co., Ltd.
06 1SHILPA PHARMA LIFESCIENCES LIMITED
07 1VALARY LAB PRIVATE LIMITED
01 2TEMOZOLOMIDE
02 6Temozolomide
03 1temozolomide
01 1China
02 2India
03 3Luxembourg
04 1Taiwan
05 2Blank
NDC Package Code : 46014-1121
Start Marketing Date : 2012-08-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46014-1450
Start Marketing Date : 2018-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46014-1460
Start Marketing Date : 2024-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66499-0015
Start Marketing Date : 2006-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0048
Start Marketing Date : 1999-08-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14778-1414
Start Marketing Date : 2011-10-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 82920-703
Start Marketing Date : 2022-08-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 81955-0014
Start Marketing Date : 2010-03-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
NDC Package Code : 83703-577
Start Marketing Date : 2009-02-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (2.5mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
90
PharmaCompass offers a list of Temozolomide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Temozolomide manufacturer or Temozolomide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Temozolomide manufacturer or Temozolomide supplier.
PharmaCompass also assists you with knowing the Temozolomide API Price utilized in the formulation of products. Temozolomide API Price is not always fixed or binding as the Temozolomide Price is obtained through a variety of data sources. The Temozolomide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CCRG 81045 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CCRG 81045, including repackagers and relabelers. The FDA regulates CCRG 81045 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CCRG 81045 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of CCRG 81045 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A CCRG 81045 supplier is an individual or a company that provides CCRG 81045 active pharmaceutical ingredient (API) or CCRG 81045 finished formulations upon request. The CCRG 81045 suppliers may include CCRG 81045 API manufacturers, exporters, distributors and traders.
click here to find a list of CCRG 81045 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing CCRG 81045 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for CCRG 81045 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture CCRG 81045 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain CCRG 81045 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a CCRG 81045 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of CCRG 81045 suppliers with NDC on PharmaCompass.
We have 5 companies offering CCRG 81045
Get in contact with the supplier of your choice:
